Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
REHEB: Entecavir Prophylaxis for HBV Reactivation in B-cell Lymphoma
NCT05453435Phase 2Active, not recruiting
- Sponsor
- Sun Yat-sen University
- Start
- Jul 2022
- Primary completion
- Dec 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of entecavir in hepatitis B (HBV), sponsored by Sun Yat-sen University. Started Jul 2022; status: active, not recruiting.
02
Drugs
entecavir
03
Conditions
hepatitis B (HBV)
Beyond the preview
Go deeper on NCT05453435.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05453435.